Contrast Enhancement and Contrast Extravasation on Computed Tomography after Intra-Arterial Thrombolysis in Patients with Acute Ischemic Stroke

Stroke

Volumn 35, Issue 4, 2004, Pages 876-881

  Yoon, Woong ^a,b   Seo, Jeong Jin ^a   Kim, Jae Kyu ^a   Cho, Ki Hyeon ^a   Park, Jin Gyoon ^a   Kang, Heoung Keun ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Blood brain barrier; Contrast media; Stroke ischemic; Thrombolytic therapy; Tomography; X ray computed

Indexed keywords

CONTRAST MEDIUM; FIBRINOLYTIC AGENT; HEPARIN; UROKINASE;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTRAST MEDIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1842471345     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000120726.69501.74     Document Type: Article

References (24)

1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1481-1587.
2. Jahan R, Duckwiler GR, Kidwell CS, Sayre JW, Gobin YP, Villablanca JP, Saver J, Slarkman S, Martin N, Vinuela F, Intraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow-up. AJNR Am J Neuroradiol. 1999;20:1291-1299.
3. Kidwell CS, Saver JL, Carneado J, Sayre J, Starkman S, Duckwiler G, Gobin YP, Jahan R, Vespa P, Villablanca JP, Licbeskind DS, Vinuela F. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke. 2002;33:717-724.
4. del Zoppo GJ, Higashida R, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase 11 randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke. 1998;29:4-11.
5. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA. 1999;282:2003-2011.
6. American Society of Interventional and Therapeutic Neuroradiology. Emergency interventional stroke therapy: a statement from the American Society of Interventional and Therapeutic Neuroradiology Stroke Task Force of the American Society of Neuroradiology and the Society of Cardiovascular and Interventional Radiology. AJNR Am J Neuroradiol. 2001;22:54-54.
7. Nakano S, Iseda T, Kawano H, Yoneyama T, Ikeda T, Wakisaka S. Parenchymal hyperdensity on computed tomography after intra-arterial reperfusion therapy for acute middle cerebral artery occlusion: incidence and clinical significance. Stroke. 2001;32:2042-2048.
8. Komiyama M, Nishijima Y, Nishio A, Khosla VK. Extravasation of contrast medium from the lenticulostriate artery following local intracarotid fibrinolysis. Surg Neurol. 1993;39:315-319.
9. Wildenhain SL, Jungreis CA, Barr J, Mathis J, Wechsler L, Horton JA. CT after intracranial intraarterial thrombolysis for acute stroke. AJNR Am J Neuroradiol. 1994;15:487-492.
10. Yokogami K, Nakano S, Ohta H, Goya T, Wakisaka S. Prediction of hemorrhagic complications after thrombolytic therapy for middle cerebral artery occlusion: value of pre- and post-therapeutic computed tomographic findings and angiographic occlusive site. Neurosurgery. 1996;39:1102-1107.
11. Urbach H, Bendszus M, Brechtelsbauer D, Solymosi L. Extravasation of contrast medium in local intra-arterial fibrinolysis of the carotid territory. Nervenarzt. 1998;69:490-494.
12. Mericle R, Lopes DK, Fronckowiak MD, et al. A grading scale to predict outcomes after intra-arterial thrombolysis for stroke complicated by contrast extravasation. Neurosurgery. 2000;46:1307-1315.
13. von Kummer R, Bourquain H, Bastianello S, et al. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology. 2001; 219:95-100.
14. Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology. 1992;42:976-982.
15. Hamann GF, Okada Y, del Zoppo GJ. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J Cereb Blood Flow Metab. 1996;16:1373-1378.
16. del Zoppo GJ, von Kummer R, Hamann GF. Ischemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry. 1998;65:1-9.
17. Hayman LA, Evans RA, Bastion FO, Hinck VC. Delayed high dose contrast CT: identifying patients at risk of massive hemorrhagic infarction. Am J Roentgenol. 1981;136:1151-1159.
18. Hornig CR, Dorndorf W, Agnoli AL. Hemorrhagic cerebral infarction-a prospective study. Stroke. 1986;17:179-185.
19. Wilcox J, Wilson AJ, Evill CA, Sage MR. A comparison of blood-brain barrier disruption by intracarotid iohexol and iodixanol in the rabbit. AJNR Am J Neuroradiol. 1987;8:769-772.
20. Harnish PP, Krutchen A, Mukherji M. Intravascular contrast media and the blood-brain barrier testing the new nonionic agent ioxilan. Invest Radiol. 1989;24:34-36.
21. Hayakawa K, Yamashita K, Mitsumori M, Nakano Y. Blood-brain barrier injury following intracarotid injection of radiographic contrast media. Acta Radiol. 1990;31:203-208.
22. Wilson AJ, Evill CA, Sage MR. Effects of nonionic contrast media on the blood-brain barrier: osmolality versus chemotoxicity. Invest Radiol. 1991;26:1091-1094.
23. Luzzani F, Morisetti A, Bussi S, Tirone P, Haen C. Neurotolerability of nonionic x-ray contrast media: the role of chemotoxicity. Invest Radiol. 1996;31:338-344.
24. Dijkhuizen RM, Asahi M, Wu O, Rosen BR, Lo EH. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model. Stroke. 2002;33:2100-2104.